Literature DB >> 25352247

The predictors of development of new syndesmophytes in female patients with ankylosing spondylitis.

K Y Kang1, S-K Kwok, J H Ju, K-S Park, S-H Park, Y S Hong.   

Abstract

OBJECTIVES: The formation of spinal syndesmophytes is an important outcome measure in ankylosing spondylitis (AS) but the predictors of new syndesmophyte development in female AS patients are unknown. This longitudinal study aimed to assess the rate and predictors of development of new syndesmophytes over a 2-year period in female AS patients.
METHOD: Clinical and radiographic data were collected at baseline and after 2 years in 67 female AS patients. Spinal radiographs were scored using the Stoke AS Spinal Score (SASSS). Univariate logistic regression analyses were performed to identify predictors associated with new syndesmophyte development.
RESULTS: Eleven (16%) patients had syndesmophytes at baseline. Nine (13.4%) patients had developed new syndesmophytes in their lumbar spines after 2 years. In the univariate logistic regression analyses, older age, longer disease duration, severe sacroiliitis, elevated C-reactive protein (CRP) levels at baseline, and one or more pre-existing syndesmophytes were associated with the occurrence of new syndesmophytes. After adjustment for baseline SASSS, increases in SASSS were statistically significantly higher in patients with elevated baseline CRP levels (p = 0.002) than in patients with normal CRP at baseline.
CONCLUSIONS: Older age, longer disease duration, severe sacroiliitis, the baseline presence of syndesmophytes, and elevated levels of CRP are predictors of the development of new syndesmophytes in female AS patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25352247     DOI: 10.3109/03009742.2014.938693

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  7 in total

Review 1.  Syndesmophyte growth in ankylosing spondylitis.

Authors:  Sovira Tan; Runsheng Wang; Michael M Ward
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

2.  Endothelial dysfunction and increased carotid intima-media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors.

Authors:  Aicha Ben Tekaya; Seif Boukriba; Ahmed Fendri; Leila Rouached; Olfa Saidane; Selma Bouden; Rawdha Tekaya; Kamel Ben Salem; Ines Mahmoud; Mizouni Habiba; Leila Abdelmoula
Journal:  RMD Open       Date:  2022-07

3.  Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis.

Authors:  Kwi Young Kang; In Je Kim; Min A Yoon; Yeon Sik Hong; Sung-Hwan Park; Ji Hyeon Ju
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

4.  Alcohol consumption as a predictor of the progression of spinal structural damage in axial spondyloarthritis: data from the Catholic Axial Spondyloarthritis COhort (CASCO).

Authors:  Hong Ki Min; Jennifer Lee; Ji Hyeon Ju; Sung-Hwan Park; Seung-Ki Kwok
Journal:  Arthritis Res Ther       Date:  2019-08-14       Impact factor: 5.156

5.  Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis.

Authors:  María Lourdes Ladehesa-Pineda; Iván Arias de la Rosa; Clementina López Medina; María Del Carmen Castro-Villegas; María Del Carmen Ábalos-Aguilera; Rafaela Ortega-Castro; Ignacio Gómez-García; Pedro Seguí-Azpilcueta; Yolanda Jiménez-Gómez; Alejandro Escudero-Contreras; Chary López Pedrera; Nuria Barbarroja; Eduardo Collantes-Estévez
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-30       Impact factor: 5.346

6.  Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy.

Authors:  Agata Sebastian; Patryk Wojtala; Łukasz Lubiński; Małgorzata Mimier; Arkadiusz Chlebicki; Piotr Wiland
Journal:  Reumatologia       Date:  2017-08-31

7.  A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis.

Authors:  Anna Deminger; Eva Klingberg; Mats Geijer; Jan Göthlin; Martin Hedberg; Eva Rehnberg; Hans Carlsten; Lennart T Jacobsson; Helena Forsblad-d'Elia
Journal:  Arthritis Res Ther       Date:  2018-08-03       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.